Purified protein delivery to activate an epigenetically silenced allele in mouse brain

Benjamin Pyles, Barbara J. Bailus, Henriette O’Geen, David Segal

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The ability to activate or repress specific genes in the brain could have a tremendous impact for understanding and treating neurological disorders. Artificial transcription factors based on zinc finger, TALE, and CRISPR/Cas9 programmable DNA-binding platforms have been widely used to regulate the expression of specific genes in cultured cells, but their delivery into the brain represents a critical challenge to apply such tools in live animals. In previous work, we developed a purified, zinc finger-based artificial transcription factor that could be injected systemically, cross the blood-brain barrier, and alter expression of a specific gene in the brain of an adult mouse model of Angelman syndrome. Importantly, our mode of delivery produced widespread distribution throughout the brain. Here we describe our most current methods for the production and purification of the factor, dosage optimization, and use of live animal fluorescence imaging to visualize the kinetics of distribution.

Original languageEnglish (US)
Title of host publicationMethods in Molecular Biology
PublisherHumana Press Inc.
Pages227-239
Number of pages13
DOIs
StatePublished - Jan 1 2018

Publication series

NameMethods in Molecular Biology
Volume1767
ISSN (Print)1064-3745

Fingerprint

Alleles
Zinc Fingers
Brain
Proteins
Transcription Factors
Clustered Regularly Interspaced Short Palindromic Repeats
Angelman Syndrome
Optical Imaging
Nervous System Diseases
Blood-Brain Barrier
Genes
Cultured Cells
Gene Expression
DNA

Keywords

  • Animal models
  • Engineered zinc finger protein
  • Gene therapy
  • Neurologic disease
  • Preclinical studies

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics

Cite this

Pyles, B., Bailus, B. J., O’Geen, H., & Segal, D. (2018). Purified protein delivery to activate an epigenetically silenced allele in mouse brain. In Methods in Molecular Biology (pp. 227-239). (Methods in Molecular Biology; Vol. 1767). Humana Press Inc.. https://doi.org/10.1007/978-1-4939-7774-1_12

Purified protein delivery to activate an epigenetically silenced allele in mouse brain. / Pyles, Benjamin; Bailus, Barbara J.; O’Geen, Henriette; Segal, David.

Methods in Molecular Biology. Humana Press Inc., 2018. p. 227-239 (Methods in Molecular Biology; Vol. 1767).

Research output: Chapter in Book/Report/Conference proceedingChapter

Pyles, B, Bailus, BJ, O’Geen, H & Segal, D 2018, Purified protein delivery to activate an epigenetically silenced allele in mouse brain. in Methods in Molecular Biology. Methods in Molecular Biology, vol. 1767, Humana Press Inc., pp. 227-239. https://doi.org/10.1007/978-1-4939-7774-1_12
Pyles B, Bailus BJ, O’Geen H, Segal D. Purified protein delivery to activate an epigenetically silenced allele in mouse brain. In Methods in Molecular Biology. Humana Press Inc. 2018. p. 227-239. (Methods in Molecular Biology). https://doi.org/10.1007/978-1-4939-7774-1_12
Pyles, Benjamin ; Bailus, Barbara J. ; O’Geen, Henriette ; Segal, David. / Purified protein delivery to activate an epigenetically silenced allele in mouse brain. Methods in Molecular Biology. Humana Press Inc., 2018. pp. 227-239 (Methods in Molecular Biology).
@inbook{debe9ceadc164bedac7207eea922a7f0,
title = "Purified protein delivery to activate an epigenetically silenced allele in mouse brain",
abstract = "The ability to activate or repress specific genes in the brain could have a tremendous impact for understanding and treating neurological disorders. Artificial transcription factors based on zinc finger, TALE, and CRISPR/Cas9 programmable DNA-binding platforms have been widely used to regulate the expression of specific genes in cultured cells, but their delivery into the brain represents a critical challenge to apply such tools in live animals. In previous work, we developed a purified, zinc finger-based artificial transcription factor that could be injected systemically, cross the blood-brain barrier, and alter expression of a specific gene in the brain of an adult mouse model of Angelman syndrome. Importantly, our mode of delivery produced widespread distribution throughout the brain. Here we describe our most current methods for the production and purification of the factor, dosage optimization, and use of live animal fluorescence imaging to visualize the kinetics of distribution.",
keywords = "Animal models, Engineered zinc finger protein, Gene therapy, Neurologic disease, Preclinical studies",
author = "Benjamin Pyles and Bailus, {Barbara J.} and Henriette O’Geen and David Segal",
year = "2018",
month = "1",
day = "1",
doi = "10.1007/978-1-4939-7774-1_12",
language = "English (US)",
series = "Methods in Molecular Biology",
publisher = "Humana Press Inc.",
pages = "227--239",
booktitle = "Methods in Molecular Biology",

}

TY - CHAP

T1 - Purified protein delivery to activate an epigenetically silenced allele in mouse brain

AU - Pyles, Benjamin

AU - Bailus, Barbara J.

AU - O’Geen, Henriette

AU - Segal, David

PY - 2018/1/1

Y1 - 2018/1/1

N2 - The ability to activate or repress specific genes in the brain could have a tremendous impact for understanding and treating neurological disorders. Artificial transcription factors based on zinc finger, TALE, and CRISPR/Cas9 programmable DNA-binding platforms have been widely used to regulate the expression of specific genes in cultured cells, but their delivery into the brain represents a critical challenge to apply such tools in live animals. In previous work, we developed a purified, zinc finger-based artificial transcription factor that could be injected systemically, cross the blood-brain barrier, and alter expression of a specific gene in the brain of an adult mouse model of Angelman syndrome. Importantly, our mode of delivery produced widespread distribution throughout the brain. Here we describe our most current methods for the production and purification of the factor, dosage optimization, and use of live animal fluorescence imaging to visualize the kinetics of distribution.

AB - The ability to activate or repress specific genes in the brain could have a tremendous impact for understanding and treating neurological disorders. Artificial transcription factors based on zinc finger, TALE, and CRISPR/Cas9 programmable DNA-binding platforms have been widely used to regulate the expression of specific genes in cultured cells, but their delivery into the brain represents a critical challenge to apply such tools in live animals. In previous work, we developed a purified, zinc finger-based artificial transcription factor that could be injected systemically, cross the blood-brain barrier, and alter expression of a specific gene in the brain of an adult mouse model of Angelman syndrome. Importantly, our mode of delivery produced widespread distribution throughout the brain. Here we describe our most current methods for the production and purification of the factor, dosage optimization, and use of live animal fluorescence imaging to visualize the kinetics of distribution.

KW - Animal models

KW - Engineered zinc finger protein

KW - Gene therapy

KW - Neurologic disease

KW - Preclinical studies

UR - http://www.scopus.com/inward/record.url?scp=85043763075&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85043763075&partnerID=8YFLogxK

U2 - 10.1007/978-1-4939-7774-1_12

DO - 10.1007/978-1-4939-7774-1_12

M3 - Chapter

C2 - 29524138

AN - SCOPUS:85043763075

T3 - Methods in Molecular Biology

SP - 227

EP - 239

BT - Methods in Molecular Biology

PB - Humana Press Inc.

ER -